Mapping the genomic landscape of antibiotic susceptiblity in Escherichia coli
Sarah Bastkowski, A. Keith Turner, Muhammad Yasir, Caroline Jarvis, Ian Charles, Mark Webber · 2026
Read Mapping the genomic landscape of antibiotic susceptiblity in Escherichia coli by Sarah Bastkowski, A. Keith Turner, Muhammad Yasir, Caroline Jarvis, Ian Charles, Mark Webber (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13645799.txt.
Description
Sarah Bastkowski led a 2026 genome-scale study mapping which genes shape Escherichia coli susceptibility to antibiotics, using a gene-disruption method called TraDIS-Xpress. Treatment failure often reflects bacteria that drugs fail to kill, yet the gene set behind it in Gram-negative bacteria was incomplete. The team disrupted genes across the E. coli K-12 genome and tested survival against thirteen antibiotics spanning major classes at multiple concentrations.
Beyond resistance genes, the core genome proved central. Disrupting energy, growth, and amino acid pathways improved survival, suggesting that slowing energy use shields cells during drug exposure. By contrast, pathways for DNA copying, cell wall and outer membrane building, transfer RNA charging, and vitamin and terpenoid making aided survival when intact. Defined mutants confirmed that breaking energy and breathing pathways protected against drug classes. Drug makers get a framework for reversing drug tolerance by targeting cell workings, not just resistance genes.
Catalog record
| CREATOR | Sarah Bastkowski, A. Keith Turner, Muhammad Yasir, Caroline Jarvis, Ian Charles, Mark Webber |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |